Mitochondrial outer membrane proteins are synthesized without a cleavable presequence but instead contain segments responsible for mitochondrial targeting and membrane integration within the molecule: the transmembrane segment (TMS) and N-or C-terminal flanking segment. We analyzed targeting and integration of Tom5, a C-tail anchor protein associated with the preprotein translocase of the outer membrane, to the yeast mitochondrial outer membrane in vivo using green fluorescent protein as the reporter and compared the signal with other signals for proteins dispersed in the membrane. The functional assembly of Tom5 into the TOM complex was assessed by blue native PAGE and complementation of temperature-sensitive ⌬tom5 cells. Correct targeting and assembly required (i) an appropriate length TMS rather than hydrophobicity, (ii) a proline residue located at correct position in the TMS and specific residues near the proline, and (iii) that, in contrast to proteins dispersed in the outer membrane, the positive C-terminal segment was dispensable. Based on these findings, we constructed green fluorescent protein fusions with a C-terminal TMS in which the deduced sequences (minimum: Ser-Pro-Met) were inserted at an appropriate position within artificial Leu-Ala repeats. They were targeted to mitochondria and complemented the temperature-sensitive growth phenotype of ⌬tom5 yeast cells. The membrane-targeting mechanism of Tom5 appears to be distinct from that for proteins that are dispersed in the outer membrane.
Most mitochondrial proteins are synthesized in the cytosol and post-translationally transported to mitochondrial subcompartments. In contrast to proteins destined for the matrix or inner membrane (1) (2) (3) , the targeting mechanism and the topogenesis of mitochondrial outer membrane proteins remains poorly understood, although targeting signals have been analyzed for several outer membrane proteins (4 -11) .
Mitochondrial outer membrane proteins are synthesized without a cleavable presequence, and the mitochondrial-targeting and topogenic information is contained within the mature protein sequence; usually within ␣-helical transmembrane segments (TMS) 1 and flanking regions (12, 13) . The import receptors of the preprotein translocase of the mitochondrial outer membrane (TOM (translocase of outer membrane) complex) (3, 14) , Tom70 (15, 16) , and Tom20 (8, 17) are anchored to the membrane through the N-terminal TMS in the Nin-Cout orientation. Tom22, which functions both as the preprotein receptor and organizer of the TOM complex, is anchored to the membrane in the Nout-Cin orientation through the internal TMS (7, 18 -20) . Tom5, Tom6, and Tom7 are anchored to the outer membrane through the C-terminal TMS (tail-anchored protein). Tom5 functions as the connecting link between import receptors and the translocation channel Tom40 (21) . Tom6 (22) (23) (24) and Tom7 (25) function as modulators of the TOM channel (26) . Tom40, like porin, is predicted to be a ␤-barrel protein spanning the outer membrane by 12-14 antiparallel ␤-strands (27) (28) (29) (30) .
The N-terminal TMS with moderate hydrophobicity and a net positive charge within five residues of the C-terminally flanking region function as the mitochondrial targeting signal of Tom20 (8) . As for tail-anchored proteins, we used yeast Tom5 and mammalian OMP25 to demonstrate that the moderate length and helical structure of the TMS and the positive charges in the C-terminal segment (C-segment) following the TMS are critical for targeting to mammalian mitochondria (11) . This signal functions only at the C terminus of the reporter protein. In mammalian cells, yeast Tom5 was not integrated into the TOM complex and behaved as a tail-anchored protein that is dispersed in the membranes. Similarly, Isenmann and Wattenberg (4) demonstrated that mitochondrial localization of VAMP-1B is determined by the C-terminal positive charge and the length of the TMS in cultured mammalian cells. Kuroda and Ito (31) and Borgese et al. (9) also demonstrated that basic amino acid residues at the C-terminal tail are critical for correct targeting of mitochondrial outer membrane cytochrome b 5 .
Systematic analysis of the targeting signal for tail-anchored proteins to mammalian mitochondria using yeast Tom5 and mammalian Omp25 indicated that the basic C-segment of Tom5, which is essential for mitochondrial targeting in mammalian cells, is dispensable in yeast. In the present study, we analyzed the characteristics of the mitochondrial-targeting signal of Tom5 in yeast cells by examining intracellular localization, assembly into the TOM complex, and the ability to com-plement temperature-sensitive (ts) ⌬tom5 cells.
These experiments revealed that the C-segment is dispensable, but a TMS with an appropriate length (17-20 residues), rather than hydrophobicity, is critical for the targeting and functional assembly into the TOM complex. In particular, a short segment containing a proline and the adjacent residues in the TMS was critical for the targeting. Unexpectedly, the TMS of Tom5 fused to the C terminus of GFP was assembled into the TOM complex and complemented the ts growth phenotype of ⌬tom5 cells. Thus, mitochondrial targeting of tail-anchored proteins destined for the TOM complex depends on a signal distinct from that of proteins that are dispersed in the membrane. The structural characteristics of the targeting signal of Tom5 might be directly recognized by Tom40 in this targeting pathway.
Based on the deduced structural characteristics of the Tom5 signal, model Leu-Ala repeats containing a stretch of proline 39 and the vicinity residues (minimum: Ser-Pro-Met) were synthesized and ligated to the C terminus of GFP. These constructs were targeted to the mitochondria and complemented ts ⌬tom5 cells, although the integration efficiency into the TOM complex was low.
In vitro import of GFP-Tom5 into mitochondria as assessed by blue native (BN)-PAGE revealed that it did not require the general import pore (GIP) during the assembly process but appeared to bind directly to the exterior of the Tom40 channel.
EXPERIMENTAL PROCEDURES
Yeast Strains and Media-The Saccharomyces cerevisiae strain SEY6210 (MAT␣ leu2-3, 112 ura3-52 his3⌬200 trp1-⌬901 lys2-801 suc2-⌬ 9 GALϩ) was used throughout the study. Yeast cells were grown at 30°C on rich medium (YPD: 2% glucose, 2% bacto-trypton (Difco), 1% Bacto-Yeast extract (Difco)). Transformants were grown on synthetic glucose medium (SD: 2% glucose, 0.67% yeast nitrogen base without amino acids (Difco), and appropriate amino acids] selective for a plasmid-borne marker, e.g. SD-His for His3-harboring plasmids. TOM5 (797552-797704 on chromosome XVI) was replaced with Candida glabrea HIS3 using a PCR-assisted disruption protocol.
Plasmid Construction-Construction of expression plasmids for enhanced GFP (EGFP) fusion proteins were based on the 2 plasmid Yeplac112 (32). The PstI/EcoRI sites in Yeplac112 were disrupted, and the ADC1 promoter and CYC1 terminator were subcloned into SphI/ EcoRI and EcoRI/HindIII sites, respectively, to create pMID-2. To construct pMID2-EGFP-Tom5, an XbaI/ApaI site was created at the EcoRI site of pMID2, into which an EGFP-Tom5 fragment that was excised from pRc/CMV EGFP-Tom5 by XbaI-ApaI was cloned. To construct pMID2-EGFP-Tom5 derivatives, pRC/CMV plasmids harboring EGFPTom5 mutants (11) were digested with XbaI and ApaI, and the obtained fragments were inserted into pMID2. To create pMID2-EGFP-Tom6, the 186-bp DNA fragment corresponding to the Tom6 ORF (full-length, 62 residues) was amplified from genomic DNA by PCR using the following primers: 5Ј-AAGCCGCGGATGGACGGTATGTTTGCT-3Ј (for the N terminus) and 5Ј-ATAGGGCCCTTATAATTGTGGGGCCAA-3Ј (for the C terminus) and cloned into the SacII/ApaI site of pMID2-EGFP. To create pMID2-EGFP-Fis1, the 108-bp DNA fragment of Fis1p (residues 181-216) was amplified from genomic DNA using oligonucleotides: 5Ј-AAGCCGCGGGAGGATAAGAYCCAGAAG-3Ј (for the N terminus) and 5Ј-ATAGGGCCCTTACCTTCTCTTGTTTCT-3Ј (for the C terminus) and cloned into pMD-EGFP. To construct pMID2-EGFPUfe1, the DNA fragment (residues 314 -346) was amplified from genomic DNA using the following oligonucleotides 5Ј-CAAGC-CGCGGGCGAAACGAGCTGCTGGAAGA-3Ј (for the N terminus) and 5Ј-ATAGGGCCCTTAACCTACATAATCTAGGAA-3Ј (for the C terminus), and the fragment was cloned into pMD-EGFP. To create pSDSuU9 (69)-RFP, the N-terminal 69 residues of preSU9 of F0-ATPase subunit 9 were ligated on the DNA level to the N terminus of DsRed (RFP) obtained from pDsRed2-N1 (Clontech), and the fragment was cloned into pMID2.
Subcellular Fractionation-Subcellular fractionation of yeast cells was performed as follows. Yeast cells (SEY6210) were transformed with pMID2-based vectors using a lithium acetate-based method and grown in SD medium without tryptophan at 30°C to an A 600 of 1.0. The cells were harvested and treated with zymolyase 100T (Seikagku America, Falmouth, MA). The spheroplasts obtained were homogenized using a polycarbonate filter (3-m pores; Nucleopore, Corning, NY). The homogenate was fractionated by differential centrifugation into P1 (6000 ϫ g, 10 min precipitate: mitochondria-rich fraction), P2 (100000 ϫ g, 30 min: microsomal fraction), and the supernatant according to the method of Daum et al. (33) . The subcellular fractions were subjected to SDS-PAGE and immunoblotting. The immunoblots were visualized by ECL (Amersham Biosciences), and the images were analyzed by LAS-1000 plus (Fuji Film, Tokyo, Japan).
Blue Native PAGE-BN-PAGE was performed essentially as described previously (34). Mitochondria were isolated from yeast cells expressing the GFP-Tom5 or the GFP-Fis1 constructs by the method described above and subjected to one-dimensional BN-PAGE as described previously (11) . The gels were subjected to immunoblotting using antibodies against EGFP (35) or rTom40 (36) .
Complementation of ts Phenotype of ⌬tom5 Yeast Cells-⌬tom5 yeast cells transformed with various pMID2-based vectors were grown overnight at 30°C in SD (ϪHis, ϪTrp) liquid culture medium. The cells grown to an A 600 of 1.0 were diluted 5-, 25-, or 125-fold, and 5-l aliquots from each dilution were plated onto two SD (ϪHis, ϪTrp) plates, which were incubated at either 30 or 37°C for 2 days.
Fluorescence Microscopy-Yeast cells were co-transformed with pMD-SU9-RFP-and pMID2-based expression plasmids for GFP-Tom5 fusions or other GFP fusions. The cells were grown on YPD medium to log phase at 30°C and then incubated with 3.7 to 5% (w/v) formaldehyde at 30°C for 30 min. The cells were isolated by centrifugation and washed twice with phosphate-buffered saline by centrifugation, suspended into VECTASHIELD (Vector Laboratories, Inc., Burlingame, CA), and placed on glass slides. Fluorescent images were taken and analyzed with a confocal laser microscope (Radiance 2000; Bio-Rad) using fluorescence images of SU9-RFP as the mitochondrial reference.
Mitochondrial Import of Preproteins in Vitro-Yeast mitochondria were isolated as described previously (37) . Mitochondrial import of reticulocyte lysate-synthesized preproteins (preadrenodoxin, porin, or GFP-Tom5) was performed essentially as described previously (36) , except that 5 mM methionine, 5 mM creatine phosphate, and 100 g/ml creatine kinase were added to the assay mixture. Where indicated, the mitochondria that were incubated with 1 M SU9-DHFR at 0°C for 15 min in the presence of 5 mM methotrexate and 1 mM NADPH were used for the import reaction. Membrane integration of 35 S-porin was assessed as follows. After import, the mitochondria were treated with 50 g/ml proteinase K at 0°C for 30 min, trichloroacetic acid-precipitated, and subjected to SDS-PAGE. Membrane integration of GFP-Tom5 was assessed as follows. After import, the mitochondria were incubated with 0.1 M Na 2 CO 3 (pH 11.5) at 0°C for 20 min, followed by ultracentrifugation to recover the membrane precipitates. The membranes were treated again with 0.1 M Na 2 CO 3 and subjected to SDS-PAGE. GFPTom5 was not recovered to the precipitate fraction in the absence of the membranes (data not shown). Analysis of the in vitro imported 35 Spreproteins by BN-PAGE was as follows. After import, the mitochondria were solubilized in 20 mM Tris-HCl buffer (pH 7.4) containing 1% digitonin, 0.1 mM EDTA, 50 mM NaCl, 10% glycerol, and 1 mM phenylmethylsulfonyl fluoride. The solubilized supernatant was subjected to one-dimensional BN-PAGE (5-16% gradient gel) followed by fluoroimage analysis using an FLA2000 (Fuji). Where indicated, mitochondria (10 g) were pretreated with 100 g/ml trypsin or proteinase K at 0°C for 30 min, followed by incubation either with soybean trypsin inhibitor or phenylmethylsulfonyl fluoride to inhibit proteases. The recovered mitochondria were subjected to the import reaction.
RESULTS

Mitochondrial Localization of GFP-Tom5 in Yeast Depends on a Signal Distinct from That for Tail-anchored Proteins
Dispersed in the Membrane-We previously analyzed the signal that directs tail-anchored proteins to mammalian mitochondria using yeast Tom5 as a model. These experiments revealed that a TMS with an appropriate length and three basic amino acid residues within the flanking five-residue segment (the C-segment) are critical. Of note, yeast Tom5 was not assembled into the mammalian TOM complex but dispersed in the membrane (11) . The signal of Omp25, a tail-anchored protein of the mammalian mitochondrial outer membrane had the same characteristics (11). Because Tom5 is firmly associated with the TOM core complex in yeast (21), we analyzed the signal responsible for targeting and integration of yeast Tom5 to yeast mitochondria.
We constructed GFP-Tom5 fusions in which deletions, insertions, or point mutations were introduced to the TMS or the C-segment, expressed in yeast, and examined the intracellular localization by confocal microscopy and subcellular fractionation (Fig. 1) . Mitochondria in yeast and COS-7 cells were stained with a RFP fusion protein carrying an N-terminal mitochondrial-targeting signal (SU9-RFP) and MitoTracker, respectively. The expressed GFP-Tom5 localized to mitochondria in both cells (Fig. 1B) . This finding was further confirmed by subcellular fractionation (Fig. 1C) . We then examined the importance of the C-segment using constructs in which three basic residues were replaced by serine residues (K-S) (Fig. 1A) .
FIG. 1.
The basic C-segment of Tom5 is not required for mitochondrial targeting and assembly into the TOM. GFP-Tom5 (WT) or the construct in which lysine residues in the C-segment were replaced with serine residues (K-S) was expressed in COS-7 or yeast cells. As the control, GFP-Fis1 or the C-segment mutant (K,R-S) was expressed in yeast cells. Mitochondria were detected by co-expression of SU9-RFP in yeast cells or co-staining with MitoTracker in COS-7 cells. Fluorescent images (green for GFP and red for RFP or MitoTracker) were obtained using confocal microscopy. Other conditions were as described under "Experimental Procedures." A, schematic representation of GFP-Tom5 and GFP-Fis1 fusion constructs. B, intracellular localization of the GFP fusions in COS-7 and yeast cells. C, cell fractionation of GFP-Tom5 or GFP-Fis1 fusions expressed in yeast cells. After cell fractionation, mitochondria (P1), ER (P2), or cytosolic (S) fractions were resolved by SDS-PAGE and subjected to Western blotting using antibodies against GFP. Endogenous Tom20 and Kar2p were also detected by immunoblotting as markers of mitochondria and ER, respectively. Note that the mitochondrial fraction (P1) was contaminated by a significant amount of the ER (P2), probably because of technical reasons. Attempts to reduce ER contamination in the mitochondrial fraction were unsuccessful. The ER-targeted GFPFis1(K,R-S) was somehow cleaved, and the fragment (asterisk) was released to the cytosolic fraction. Attempts to inhibit this cleavage were also unsuccessful. D, integration of GFP-Tom5 constructs into the TOM complex as detected by BN-PAGE. E, complementation of the ts growth defect of ⌬tom5 yeast cells by GFP-Tom5 fusions. ⌬tom5 yeast cells were transformed by the indicated GFP-Tom5 fusions, and the transformants were each plated on two sets of SD plates with 5-fold serial dilutions. The plates were incubated for 2 days at 30°C or 37°C. Intracellular localization of the expressed constructs as assessed by confocal microscopy is shown on the right side of the panel. Mt, mitochondria; Cyt, cytoplasm.
GFP-Tom5(K-S) was dispersed throughout the membranes in COS-7 cells (Fig. 1B) , confirming our previous finding. In yeast cells, it was unexpectedly correctly localized to mitochondria (Fig. 1, B and C) , indicating that the basic C-segment is dispensable for correct targeting in yeast. The TMS-deleted construct GFP-Tom5(⌬TM) localized to the cytosol (Figs. 1C and  2B ). BN-PAGE indicated that GFP-Tom5(K-S) was efficiently integrated into the ϳ400-kDa TOM complex (Fig. 1D) . Furthermore, GFP-Tom5 constructs (wild type and K-S) but not GFP-TOM5(⌬TM) complemented the ts growth defect of ⌬tom5 yeast cells (Fig. 1E) . The C-segment-deleted mutant GFP-Tom5(⌬C) showed the same phenotype as GFP-Tom5(K-S) (data not shown). Thus, correct targeting and functional integration of Tom5 into the yeast TOM complex does not require the basic C-segment.
We then examined the targeting properties of yeast Fis1, a tail-anchored outer membrane protein that is dispersed in the membrane. Fis1p is anchored to the mitochondrial outer membrane through a 20-amino acid C-terminal TMS followed by a 5-residue C-segment with four basic charges (Fig. 1A) . Fis1p functions in conjunction with a peripheral protein, Mdv1p, and a cytosolic dynamin-like protein, Dnm1p, to regulate mitochondrial fission reactions (38) . Expression of GFP-Fis1 in yeast cells localized to the mitochondria, whereas the C-segment mutant (GFP-Fis1(K,R-S)) was mistargeted to the ER and cofractionated with Kar2p (Fig. 1, B and C; during cell fractionation the ER-targeted construct was somehow cleaved, and the fragment was released to the cytosol (asterisk)), thus confirming, also in yeast, the importance of the basic C-segment for mitochondrial targeting of the membrane-dispersed tail-anchored proteins. GFP-Fis1 failed to assemble into the TOM complex (Fig. 1D) and to complement the ts growth defect of the ⌬tom5 yeast cells (Fig. 3C) . These results indicated that the mitochondrial-targeting signal of Tom5 is clearly distinct from the signal of tail-anchored proteins dispersed in the outer membrane.
Length of TMS Rather Than Hydrophobicity Is Critical for Targeting and Integration of GFP-Tom5
Fusions to the TOM Complex-We then examined the importance of TMS for the functional targeting of GFP-Tom5. TM(ϩ1V), in which the TMS was elongated by a valine residue, localized to the mitochondria, whereas TM(ϩ3V) and TM(ϩ5V) were targeted mainly to the ER as judged by co-localization with Kar2p and cell fractionation (Fig. 2, A-C) . TM(ϩ1V) complemented the ts growth defect of ⌬tom5 cells (Fig. 2D) . TM(ϩ2V) localized to the mitochondria (Fig. 2, B and C) , although it failed to comple- FIG. 2. TMS length, rather than hydrophobicity, is critical for the mitochondrial targeting. A, schematic representation of the TMS-elongated GFPTom5 fusion constructs. B, intracellular localization in yeast of GFP-Tom5 constructs in which valine residues were inserted in the TMS or hydrophobicity of the TMS was increased by partial replacement of the N-and C-terminal regions with valine and leucine residues, respectively. The results of confocal microscopy are shown. ER was located by immunostaining using anti-Kar2p antibodies. TM(ϩ5V) mostly localized to the ER, although a small fraction was presumably transported further to the downstream secretory organelles of dot-like structures. C, subcellular localization of the GFP-Tom5 constructs as revealed by immunoblotting. D, complementation of ts growth of ⌬tom5 cells. E, assembly of GFP-Tom5 fusions into the TOM complex as revealed by BN-PAGE. Other conditions were as described in Fig. 1 and "Experimental Procedures." WT, wild type. ment the ts growth defect of ⌬tom5 yeast cells (Fig. 2D) , indicating that the length of TMS is critical for association with the TOM complex. BN-PAGE was used to confirm that TM(ϩ2V) was not assembled into the TOM complex (Fig. 2E) . Furthermore, the C-segment mutant TM(ϩ2V)/K-S, in which positive charges were depleted, localized to the ER (Fig. 2, B and C) , consistent with previous results. Together, these results indicate the presence of two targeting pathways for mitochondrial tail-anchored proteins: the C-segment-dependent and -independent pathways.
We then examined the effect of hydrophobicity in the TMS on mitochondrial targeting. The N-and C-terminal segments of the TMS of GFP-Tom5 were replaced by valine and leucine residues to increase hydrophobicity without changing the length ((TM(VL)) ( Fig. 2A) . This manipulation increased the average hydrophobicity from 1.28 to 2.44. It did not affect mitochondrial-targeting of the fusion construct (Fig. 2, B and  C) , and the construct assembled into the TOM complex and complemented the ts growth defect of the ⌬tom5 yeast cells (Fig. 2, D and E) . These results indicated that the length of TMS rather than hydrophobicity is critical for correct targeting.
Proline 39 in the TMS Is Critical for Functional Targeting of Tom5-Allen et al. (39) demonstrated that a conserved proline residue present in the TMS of yeast mitochondrial tail-anchored proteins, such as Tom5, Tom6, Tom7, and Tom22 is required for targeting to the outer membrane. We analyzed this in more detail with GFP-Tom5 mutants carrying deletions within the TMS (summarized in Table I ). Single deletions within residues 43-45 did not affect localization of the constructs. The same was true for residues 30 -36 and 38. In contrast, deletion of either of residues 37, 40, 41, or 42 decreased targeting fidelity and induced partial mislocalization of the constructs to the cytosol. Most dramatically, deletion of the proline at residue 39 induced complete mislocalization of the construct (GFP-Tom5(⌬39P)) to the ER. It also failed to complement the ts growth defect of the ⌬tom5 cells (Table I) . Similar results were obtained with the mutant in which proline 39 was replaced by leucine (GFP-Tom5(P39L)); it mislocalized to dot-like structures that probably represent secretory organelles and, therefore, failed to complement the ts growth defect of the ⌬tom5 cells (data not shown). The other GFPTom5 constructs with a single-residue deletion in residues 40 -45 complemented the ts growth defect of the ⌬tom5 cells (Table I) , of which ⌬44 -45 and ⌬44L were confirmed to be integrated into the TOM complex (data not shown). The constructs carrying a single residue-deletion within residues 30 -38 were targeted to the mitochondria. Deletions within residues 35-38 compromised the complementation activity of GFP-Tom5, whereas those within the N-terminal periphery of the TMS (residues 30 -34) did not (Table I) . Neither the complementation activity nor the mitochondria-targeting function was compromised by the replacement of any of residues 35-38 by alanine (data not shown), suggesting that the 35-38 stretch did not require specific amino acid residues but that the length is critical.
To summarize, proline 39 is most critical for functional assembly into the TOM complex, and the mutation or deletion of proline induced mislocalization to the ER pathway. The residues localizing in the C-terminal vicinity of proline 39 mainly affected the targeting efficiency, whereas those in the N-terminal vicinity (residues 35-38) affected functional complementation. The defect of assembly into the TOM complex was confirmed for several of the complementation-defective constructs
FIG. 3. TMS of Tom5 can complement the ts growth defect of ⌬tom5 cells. The indicated GFP fusion constructs (A)
were examined for the intracellular localization using confocal microscopy (B) and for complementation of the ts growth defect of ⌬tom5 cells (C). Note that the C-segment of the ER resident protein Ufe1 was replaced by the corresponding region of Tom5 so that the fusion construct could be targeted to mitochondria. D, Tom5⌬1-22 was expressed in yeast cells, and integration of the constructs into the TOM complex was detected by BN-PAGE.
(for ⌬37V and ⌬38S; data not shown). ⌬35L was targeted to mitochondria and exhibited strong growth inhibition of ⌬tom5 cells at a nonpermissive temperature for unknown reasons (Table I, 
footnote a).
We then addressed the importance of the proline residue position in the TMS (summarized in Table II ). When proline 39 was shifted toward the C terminus by one or two residues, the mutants ⌬39P/ϩ40P and ⌬39P/ϩ41P were more or less targeted to the mitochondria and complemented the ts growth defect of ⌬tom5 cells, whereas ⌬39P/ϩ42P and ⌬39P/ϩ43P mislocalized mainly to the cytosol and did not, or only weakly, complemented the growth defect. On the other hand, when proline 39 was shifted toward the N terminus in the TMS, the mutants (⌬39P/ϩ38P, ⌬39P/ϩ37P, ⌬39P/ϩ35P, and ⌬39P/ ϩ33P) were mainly targeted to the ER pathways. We further confirmed that these constructs could not, or could only weakly, complement the ts growth defect of the ⌬tom5 cells. Similarly, GFP-Tom5/ϩ33P, in which a proline residue was inserted at position 33 to keep proline 39 intact, localized to the mitochondria and cytosol but failed to complement the ts growth defect of the ⌬tom5 cells (data not shown). These results suggest that the region upstream of proline 39 in the TMS should be in a helical structure for correct targeting to the TOM complex (Chaw-Fassmann's algorithm predicts a helical structure for residues 5-50; not shown).
Taken together, these findings indicated that the proline residue should be located in the appropriate position (within residues 39 -41, or within 5-7 residues from the C-terminal border of the membrane) for functional mitochondrial targeting.
Tom5 TMS Contains the Targeting and Insertion Function-
The N-terminal segment of Tom5 is rich in acidic amino acid residues that are considered to function during preproteintransfer from Tom22 to Tom40 (21) . Unexpectedly, GFPTom5⌬1-22, which lacks the acidic N-terminal 22 residues of Tom5, was targeted to mitochondria and complemented the ts growth defect of ⌬tom5 cells (Fig. 3, B and C) . The basic charges in the C-segment were not required for mitochondrial localization and growth complementation (Tom5⌬1-22(K-S) in Fig. 3 , B and C). As a control, the TMS of Fis1 or the tail-anchored tSNARE of the ER, Ufe1 (40), was not functional, although they were targeted to mitochondria (Fig. 3, B and C, and data not shown; the C-segment of Ufe1 was replaced by that of Tom5 to produce mitochondrial localization), thus indicating that this complementation was not due to nonspecific interactions of the hydrophobic TMS of tail-anchored proteins. BN-PAGE revealed that GFP-Tom5⌬1-22 was integrated into the TOM complex (Fig. 3D) . These results suggested that the N-terminal cytoplasmic domain of Tom5 is dispensable for membrane targeting and functional assembly into the TOM.
GFP Fusions with the Tom5 Model TMS Complement the ts Growth Defect of ⌬tom5
Cells-Thus, the minimum requirement for mitochondrial targeting and complementation of the ts growth defect of ⌬tom5 cells was determined. The structural requirements were (i) a TMS of 17-020 residues, (ii) a proline residue positioned 5-7 residues from the C-terminal border of the TMS, (iii) specific amino acid residues in the N-terminal vicinity of proline 39, and (iv) a presumed helical structure of the region upstream of proline 39 in the TMS. Based on these requirements, we constructed artificial 19-residue TMS in which a stretch of proline 39 and the vicinity residues in the Tom5 TMS was inserted into Leu-Ala repeats so that the proline residue could be positioned 7 residues from the C-terminal border of the membrane and ligated them to the C terminus of GFP (Fig. 4A) . The constructs (LA)7/VSPMI and (LA)8/SPM were targeted to the mitochondria and complemented the ts growth defect of the ⌬tom5 yeast cells (Fig. 4, B and C) , although they had a targeting fidelity lower than constructs with authentic Tom5 TMS and some fraction localized to the ER (Fig. 4B and data not shown) . In contrast, (LA)6/FLWVSPM efficiently targeted to mitochondria and complemented the ts growth defect of the ⌬tom5 yeast cells (Fig. 4, B and C) . On the other hand, the GFP constructs fused to the synthetic Leu-Ala repeats with a proline insertion, (LA)7/P and (LA)9/P, were targeted to the mitochondria and ER, respectively, and failed to complement the ts growth defect of ⌬tom5 cells (Fig. 4, B and C, and data not shown).
BN-PAGE revealed that the constructs with artificial TMS that complemented ts ⌬tom5 cells were integrated into the TOM complex but with lower integration efficiency; (LA)7/ VSPMI and (LA)8/SPM might have dissociated from the TOM complex during electrophoresis because of low affinity (Fig.  4D) . We concluded that the model sequence containing Ser-ProMet is the minimum signal for membrane targeting and assembly into the TOM complex.
GFP-Tom5 Does Not Share the General Import Pore with Matrix-targeted Preproteins-We then probed the targeting and insertion pathway of GFP-Tom5 to the mitochondrial outer Wild type
TEKTLKQAAYVAAFLWVSPMIW-KKQWK Mt/Cyt ϩϩ a Yeast cells expressing GFP-Tom5(⌬35L) exhibit growth defect even at nonpermissive temperature.
membrane. The in vitro insertion of GFP-Tom5 revealed that neither the surface import receptors nor GIP that are normally used by presequence-containing preproteins were involved (Fig. 5) . When the GIP of the outer membrane was blocked by accumulating chemical amounts of a translocation intermediate of the fusion protein SU9-dihydrofolate reductase (SU9-DHFR) in the presence of methotrexate and NADPH, the import of matrix-targeted preprotein preadrenodoxin was strongly blocked (Fig. 5A, left panel) . Under the same condition, insertion of the outer membrane protein porin, which also requires GIP for the membrane insertion (41) was inhibited by ϳ30% (Fig. 5A, middle panel) . The import of porin into ⌬tom5 mitochondria was reduced relative to wild type mitochondria, confirming the previous report (21) , and the import was significantly blocked by the addition of SU9-DHFR (Fig. 5A, middle  panel) . These results verified that the GIP was satisfactorily occupied by SU9-DHFR. In contrast, however, neither of the above manipulations inhibited alkaline-resistant integration of GFP-Tom5 into mitochondria (Fig. 5A, right panel) . Similar results were obtained for porin and GFP-Tom5 when their assembly into the oligomeric structures was monitored by BN-PAGE. The assembly of porin (41) was inhibited by either GIP blockade or combination of the Tom5 depletion and GIP blockade, whereas the assembly of GFP-Tom5 into the TOM complex was not (Fig. 5B) . Furthermore, trypsin treatment of mitochondria to remove import receptors or proteinase K treatment to remove Tom40 significantly compromised the membrane integration of porin (Fig. 5C) , confirming a previous report that the insertion of porin occurs via the import receptor Tom20 and GIP (41) . In contrast, assembly of GFP-Tom5 into the TOM complex was not affected by trypsin treatment, whereas proteinase K treatment to decrease the Tom40 level significantly compromised its assembly (Fig. 5C ), suggesting that integration of GFP-Tom5 required Tom40 but not the import receptors. Together, these data suggested that the Tom5 precursor binds directly to the exterior part of the Tom40 channel.
DISCUSSION
In the present study, we characterized the Tom5 signal required for targeting and functional assembly into the TOM complex in yeast cells and compared it with the signal that directs membrane-dispersed tail-anchored proteins to the outer membrane. The structural characteristics of the signal are in marked contrast to those of proteins not restricted to the TOM complex that are dispersed in the outer membrane. The signal of the dispersed proteins required an appropriate length ␣-helical TMS and the following basic C-terminal segment (11) . The proline residue was not critical for targeting (see Fis1 in Fig. 1,   FIG. 5 . Membrane integration of GFP-Tom5 depends on Tom40 but is insensitive to the blockade of the Tom40 channel by the addition of SU9-DHFR. A, the indicated preproteins were synthesized in reticulocyte lysate system and imported into the mitochondria isolated from ⌬tom5 yeast cells or isogenic cells. Where indicated, the mitochondria were preincubated with chemical amounts of SU9-DHFR in the presence of methotrexate and NADPH to block GIP. Other conditions were described under "Experimental Procedures." B, reticulocyte lysatesynthesized and 35 S-labeled porin or GFP-Tom5 was incubated with the mitochondria isolated from ⌬tom5 or wild type (WT) cells followed by analysis of assembly into the oligomeric structures using BN-PAGE and fluoroimage analysis. The band intensities were quantified, setting the signal obtained for the wild type mitochondria as 100%. C, reticulocyte lysate-synthesized and 35 S-labeled porin or GFP-Tom5 was imported into trypsin-or proteinase K-pretreated mitochondria. After import, the recovered mitochondria were subjected to BN-PAGE. Following fluoroimage analysis, the amounts of Tom40, Tom20, and mhsp70 in the mitochondria used for the import assay were analyzed by immunoblotting. pAd, preadrenodoxin.
A and B). These structural characteristics are conserved in yeast and mammals, although a slightly longer or a slightly more hydrophobic TMS is required in mammals (11).
Allen et al. (39) demonstrated that a conserved proline residue in the TMS of Tom7 and other tail-anchored subunits of the TOM complex, Tom6, Tom5, and intermembrane anchor Tom22 is required for their efficient targeting to the outer membrane. Our detailed study with yeast Tom5 has validated this and further revealed that proline and the adjacent residues are critical and should be located within a narrow range from the C-terminal border of the membrane. These characteristic features of Tom5 are not conserved in other tail-anchored components of the TOM complex. In fact, the Tom6 TMS could not replace the function of Tom5 in our study (data not shown). Dembowski et al. (10) demonstrated with Neurospora crassa Tom6 that the C-terminal domain consisting of the 16-residue TMS and the 6-residue C-segment with a net negative charge contains the information required for the initial recognition of Tom6, and an additional nonconserved N-terminal flanking region (within 26 residues) of the TMS is required for assembly into the TOM complex. Membrane insertion of Tom6 depends on surface receptors (10) . Import of Tom22, a bitopic outer membrane protein with an Nout-Cin orientation, depends on the surface import receptors Tom70 and Tom20 (18) . In vitro import experiments with N. crassa Tom22 revealed that a 30-residue segment with a net positive charge is essential for the import, whereas a short N-terminal flanking region of the TMS enhances import efficiency (20) . In vivo study in S. cerevisiae revealed that 13 residues at the N-terminal flanking region of the TMS are required for Tom22 mitochondrial targeting (7). Therefore, Tom subunits with a tail anchor or internal anchor are targeted and assembled to the TOM complex using their unique signals.
GFP-Tom5 constructs carrying a single-residue deletion within residues 35-38 in the TMS were targeted to the mitochondria, although they were not integrated into the TOM complex and failed to complement the ts growth defects of ⌬tom5 cells. Constructs with an alanine substitution in these regions, however, were efficiently integrated into the TOM complex and complemented the ts growth defect of ⌬tom5 cells. Similarly, the TMS-elongated construct TM(ϩ2V) was inserted into the mitochondrial outer membrane without being incorporated into the TOM complex. These results indicate that the length of TMS, especially in the N-terminal region of proline 39, is critical for assembly into the TOM complex.
Tom5 is required for the import of cleavable and noncleavable preproteins at a post-receptor stage between Tom22 and Tom40, and the negative net charge of its cytosolic segment is expected to facilitate interaction with positively charged targeting sequences (21) . In fact, the antibody raised against an N-terminal peptide of Tom5 preadsorbed to mitochondria inhibited import of the ADP/ATP carrier to the general import pore stage (21) . Unexpectedly, however, Tom5 TMS fused to the C terminus of GFP (Tom5⌬1-22) was integrated into the TOM complex and complemented the ts growth defect of ⌬tom5 cells. As a control, TMS of Fis1, Ufe1, or Tom6 (data not shown) fused to the C terminus of GFP failed in this complementation, indicating that the complementation is specific for the Tom5 TMS. BN-PAGE revealed that Tom5⌬1-22 was assembled into the TOM complex, although the efficiency was slightly lower than that of GFP-Tom5 (Fig. 3) . These results suggest that the cytosolic negatively charged segment of Tom5 is dispensable for function. At present, we have no explanation for this discrepancy in the functional importance of the acidic cytoplasmic segment.
What component initially recognizes these structural features of Tom5 TMS? In the in vitro import assay, small Tom proteins Tom5 and Tom7 are inserted directly into the mature ϳ400-kDa TOM complex, whereas Tom6 is inserted into the ϳ100-kDa intermediate complex before maturation to the 400-kDa complex (42) . On the other hand, when radiolabeled Tom40 precursor is imported into mitochondria, it is first targeted to the membrane via the receptor proteins Tom20 and Tom22 and then assembles with endogenous Tom5 to form the intermediate 250-kDa complex exposed to the intermembrane space. The 250-kDa complex then matures to a 400-kDa complex via a 100-kDa intermediate. These results also suggest that newly synthesized Tom5 directly binds to Tom40 in the maturation pathway of the TOM complex. In both cases, therefore, Tom40 functions as the receptor for Tom5. In addition, we demonstrated here that GFP-Tom5 was inserted irrespective of the blockade of the GIP, in marked contrast to N. crassa Tom6 and Tom7, whose assembly into the TOM complex occurs via the GIP (10) . Together, these results suggest that Tom5 binds directly to the exterior site of the Tom40 channel in the TOM complex. If this is the case, then the structural characteristics of the determined signal might be required to fit with the surface of the predicted ␤-barrel structure of the Tom40 channel. When this configuration is disrupted, the protein is no longer recognized by Tom40 and is mistargeted to the ER via a post-translational targeting pathway and probably assisted by cytoplasmic chaperones.
The insertion pathway of the basic C-segment-dependent tail anchor protein into the mitochondrial outer membrane remains unclear. Our preliminary results indicated that insertion of GFP-Fis1 was insensitive to blockade of the GIP by the addition of SU9-DHFR. 2 Motz et al. (43) recently demonstrated in yeast that mitochondrial targeting of Bcl2 requires two basic residues in the C-segment, and its insertion depends on the import receptor Tom20, bypassing the GIP or the TOM core complex. It should be clarified, therefore, whether this is the general import pathway for the tail-anchored mitochondrial outer membrane proteins that are targeted in the basic Csegment dependent fashion.
